HCW Biologics Inc. - 8-K Filing
HCW Biologics reports Q3 2026 revenue of $55,463 and net loss of $3.2 million while noting going concern doubt. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $HCWB
Read the full article at SEC EDGAR
Part of the story Veritone Announces Restructuring Plan and $40 Million Debt Commitment to Reach Profitability (4 articles)